Skip to main content

Table 3 Results for treatment impact given as the baseline compared to end results for the final exam before sacrifice (mean ± standard deviation)

From: Multiple ultrasound cavitation-enabled treatments for myocardial reduction

  Echo wall (mm) Ejection Fraction Echo Strain (%) Displace. (mm) Histo wall Fibrosis
Group Baseline End Baseline End Baseline End Baseline End mm Area %
A 1.7 ± 0.1 1.7 ± 0.1 80 ± 3 77 ± 1 51 ± 7 46 ± 4 0.88 ± 0.13 0.76 ± 0.08 2.3 ± 0.4 0
B 1.7 ± 0.1 2.0 ± 0.1** 79 ± 1 75 ± 2** 45 ± 8 30 ± 5** 0.92 ± 0.06 0.76 ± 0.08* 2.4 ± 0.2 40 ± 10a
C 1.8 ± 0.1 1.9 ± 0.2* 80 ± 4 77 ± 5 46 ± 5 36 ± 8* 0.87 ± 0.08 0.84 ± 0.11 2.4 ± 0.4 29 ± 16a
D 1.9 ± 0.2 1.5 ± 0.2** 79 ± 3 65 ± 6** 45 ± 7 25 ± 7** 0.88 ± 0.08 0.54 ± 0.11** 1.8 ± 0.3a 49 ± 8a
  1. Significant differences versus baseline denoted by * for p < 0.05 or ** for p < 0.01. Significant difference versus sham (A) denoted by a. In addition, the fibrosis was higher in D than in C (p < 0.05), but there was no significant differences for the other comparisons (B versus C, and B versus D)